Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Propofol: the ideal long-term sedative?]

A Wiebalck1, H Van Aken

  • 1Department of Anaesthesiology, University Hospitals, Katholieke Universiteit Leuven, Belgium.

Der Anaesthesist
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Handling of COVID-19 in the emergency department : Field report of the emergency ward of the University Hospital Münster].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2020
Same author

[Comment on: What is the appropriate anesthesia for thrombectomy?]

Der Anaesthesist·2017
Same author

Post-traumatic pain. Causes and therapeutic concepts.

Der Orthopade·2017
Same author

[Survey of pain after ambulatory surgery: An internet-based instrument].

Schmerz (Berlin, Germany)·2015
Same author

GDF-15 prevents ventilator-induced lung injury by inhibiting the formation of platelet-neutrophil aggregates.

Thrombosis and haemostasis·2015
Same author

Hydroxyethyl starch 130/0.4 decreases inflammation, neutrophil recruitment, and neutrophil extracellular trap formation.

British journal of anaesthesia·2014
Same journal

[Promoting young academics in anesthesiology: factors for an attractive internship].

Der Anaesthesist·2022
Same journal

[Respiratory support in COVID-19: all in due time!]

Der Anaesthesist·2022
Same journal

[Noninvasive respiratory support and invasive ventilation in COVID‑19 : Where do we stand today?]

Der Anaesthesist·2022
Same journal

[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine].

Der Anaesthesist·2022
Same journal

[Anesthesia in patients with acute porphyria].

Der Anaesthesist·2022
Same journal

[Quality and safe anesthesia for all children : That is their right!]

Der Anaesthesist·2022
See all related articles

Propofol offers excellent control for short-term sedation in ICUs. However, potential cardiovascular side effects and long-term issues mean it may not be the ideal choice for extended sedation.

Area of Science:

  • Anesthesiology
  • Pharmacology

Context:

  • Propofol, an anesthetic agent, is widely used for sedation in intensive care units (ICUs).
  • Its formulation as an emulsion allows for intravenous administration.
  • It has been utilized for sedation since 1986.

Purpose:

  • To evaluate the suitability of propofol for long-term sedation in intensive care settings.
  • To discuss the benefits and limitations of propofol for prolonged use.

Summary:

  • Propofol provides effective sedation with excellent control, facilitating neurological monitoring and rapid patient recovery.
  • It aids in mechanical ventilation by depressing spontaneous breathing and does not impair cerebral autoregulation.
  • The lipid emulsion contributes to parenteral nutrition.

Related Experiment Videos

Impact:

  • While propofol is valued for its rapid onset and offset, potential cardiovascular depression and risks like hypertriglyceridemia require consideration for long-term use.
  • Further long-term studies are needed to definitively establish propofol as an ideal agent for extended sedation.
  • Cardiovascular side effects may be exacerbated by concurrent medications.